Showing results (501-510 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|April 17, 2020
Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication)Jun Ishigooka, Tomohiro Usami, Shuichi Iwashita, et al.Neuropsychopharmacology Reports|April 9, 2020
Apathy symptoms induced by low-dose venlafaxine: Two casesShinji Sato, Noriko Sodeyama, Asaki Matsuzaki, et al.Neuropsychopharmacology Reports|April 9, 2020
Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorderFavour Omileke, Sayuri Ishiwata, Junko Matsuo, et al.Neuropsychopharmacology Reports|May 1, 2020
Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic-like effects without affecting cognitive enhancement and cataleptic effects in ratsKeita Arakawa, Shunsuke MaeharaNeuropsychopharmacology Reports|August 29, 2025
Nonresponse to Ketamine in Treatment-Resistant Bipolar DepressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.Neuropsychopharmacology Reports|February 22, 2021
Effects of age and sex on eye movement characteristicsJunichi Takahashi, Kenichiro Miura, Kentaro Morita, et al.Neuropsychopharmacology Reports|October 25, 2018
Risk factors for pneumonia in patients with schizophreniaTakahiro Haga, Kae Ito, Kentaro Sakashita, et al.Neuropsychopharmacology Reports|March 6, 2021
Dietary magnesium deficiency induces the expression of neuroinflammation-related genes in mouse brainRyuhei Tsuji, Hirofumi Inoue, Mariko Uehara, et al.Neuropsychopharmacology Reports|March 2, 2021
Validation of hair ethyl glucuronide using transdermal monitoring and self-reported alcohol use in women of childbearing potentialAndrea L Blair, Ashleigh L Chiaf, Erica K Crockett, et al.Neuropsychopharmacology Reports|November 2, 2022
Risk assessment of accidental falls in patients taking trazodone, quetiapine, or risperidone for insomnia: A single-center, case-control studyYoshihito Shimizu, Masatoshi Taga, Yoshimitsu Takahashi, et al.Pageof 66